RELONCHEM LIMITED

04773758
Active Widnes

Wholesale of pharmaceutical goods

16 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
R

RELONCHEM LIMITED

04773758

Wholesale of pharmaceutical goods

Founded 21 May 2003 Active Widnes, England 16 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
Accounts Submitted 4 Jun 2026 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 2 Jun 2025 Next due 4 Jun 2026 13 days overdue
Net assets £61M £11M 2024 year on year
Total assets £66M £9M 2024 year on year
Total Liabilities £5M £2M 2024 year on year
Charges 2
2 satisfied

Contact & Details

Contact

Registered Address

Cheshire House Gorsey Lane Widnes Cheshire WA8 0RP England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for RELONCHEM LIMITED (04773758), an active life sciences and medical technology company based in Widnes, England. Incorporated 21 May 2003. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type full
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

£23.54M

Increased by £8.81k (+0%)

Net Assets

£61.28M

Increased by £11.38M (+23%)

Total Liabilities

£5.12M

Decreased by £2.46M (-33%)

Turnover

£55.12M

Increased by £8.60M (+18%)

Employees

16

Increased by 2 (+14%)

Debt Ratio

8%

Decreased by 5 (-38%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Marksans Pharma U.k. Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

RELONCHEM LIMITED Current Company

Charges

Charges

2 satisfied

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Unit S3, School Lane, Knowsley Business Park, Prescot KNOWSLEY
Leasehold-28 Feb 2019
Unit S3, School Lane, Knowsley Business Park, Prescot
Leasehold
Added 28 Feb 2019
District KNOWSLEY

Documents

Company Filings

DateCategoryDescriptionDocument
4 Jun 2026AccountsAnnual accounts made up to 31 Mar 2026
15 Apr 2026OfficersAppointment of Mr Daniel Chisnall as director on 1 Apr 2026
1 Apr 2026OfficersTermination of John Stephen Molyneux as director on 31 Mar 2026
3 Jul 2025OfficersAppointment of Mr Daniel Chisnall as director on 25 Jun 2025
3 Jul 2025OfficersAppointment of Mr Abhinna Sundar Mohanty as director on 25 Jun 2025
4 Jun 2026 Accounts

Annual accounts made up to 31 Mar 2026

15 Apr 2026 Officers

Appointment of Mr Daniel Chisnall as director on 1 Apr 2026

1 Apr 2026 Officers

Termination of John Stephen Molyneux as director on 31 Mar 2026

3 Jul 2025 Officers

Appointment of Mr Daniel Chisnall as director on 25 Jun 2025

3 Jul 2025 Officers

Appointment of Mr Abhinna Sundar Mohanty as director on 25 Jun 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Mar 2026

1 weeks ago on 4 Jun 2026

Appointment of Mr Daniel Chisnall as director on 1 Apr 2026

2 months ago on 15 Apr 2026

Termination of John Stephen Molyneux as director on 31 Mar 2026

2 months ago on 1 Apr 2026

Appointment of Mr Daniel Chisnall as director on 25 Jun 2025

11 months ago on 3 Jul 2025

Appointment of Mr Abhinna Sundar Mohanty as director on 25 Jun 2025

11 months ago on 3 Jul 2025